CIK 1940272
ADAR1 Capital Management, LLC
Institutional 13F holdings & portfolio
Holdings
512
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 251–300 of 512
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| BSAAU | BEST SPAC I ACQUISITION CORP | 100K | $1M+ | SH |
| BSAAU | BEST SPAC I ACQUISITION CORP | 100K | $1M+ | SH |
| MRK | MERCK & CO INC | 10K | $1M+ | SH |
| MRK | MERCK & CO INC | 10K | $1M+ | SH |
| CCCX | CHURCHILL CAP CORP X | 65K | $1M+ | SH |
| CCCX | CHURCHILL CAP CORP X | 65K | $1M+ | SH |
| EA | ELECTRONIC ARTS INC | 5K | $1M+ | SH |
| EA | ELECTRONIC ARTS INC | 5K | $1M+ | SH |
| MCK | MCKESSON CORP | 1K | $500K+ | SH |
| MCK | MCKESSON CORP | 1K | $500K+ | SH |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 39K | $500K+ | SH |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 39K | $500K+ | SH |
| BNTX | BIONTECH SE | 10K | $500K+ | SH |
| BNTX | BIONTECH SE | 10K | $500K+ | SH |
| VKTX | VIKING THERAPEUTICS INC | 26K | $500K+ | SH |
| VKTX | VIKING THERAPEUTICS INC | 26K | $500K+ | SH |
| UTHR | UNITED THERAPEUTICS CORP DEL | 2K | $500K+ | SH |
| UTHR | UNITED THERAPEUTICS CORP DEL | 2K | $500K+ | SH |
| PLYM | PLYMOUTH INDL REIT INC | 41K | $500K+ | SH |
| PLYM | PLYMOUTH INDL REIT INC | 41K | $500K+ | SH |
| KVAC | KEEN VISION ACQUISITION CORP | 75K | $500K+ | SH (Call) |
| KVAC | KEEN VISION ACQUISITION CORP | 75K | $500K+ | SH (Call) |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 117K | $500K+ | SH |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 117K | $500K+ | SH |
| DNLI | DENALI THERAPEUTICS INC | 52K | $500K+ | SH |
| DNLI | DENALI THERAPEUTICS INC | 52K | $500K+ | SH |
| XNCR | XENCOR INC | 56K | $500K+ | SH |
| XNCR | XENCOR INC | 56K | $500K+ | SH |
| LQDA | LIQUIDIA CORPORATION | 25K | $500K+ | SH (Put) |
| LQDA | LIQUIDIA CORPORATION | 25K | $500K+ | SH (Put) |
| KLRS | KALARIS THERAPEUTICS INC | 100K | $500K+ | SH |
| KLRS | KALARIS THERAPEUTICS INC | 100K | $500K+ | SH |
| QNRX | QUOIN PHARMACEUTICALS LTD | 58K | $500K+ | SH |
| QNRX | QUOIN PHARMACEUTICALS LTD | 58K | $500K+ | SH |
| DYN | DYNE THERAPEUTICS INC | 43K | $500K+ | SH |
| DYN | DYNE THERAPEUTICS INC | 43K | $500K+ | SH |
| AZN | ASTRAZENECA PLC | 9K | $500K+ | SH |
| AZN | ASTRAZENECA PLC | 9K | $500K+ | SH |
| GILD | GILEAD SCIENCES INC | 7K | $500K+ | SH |
| GILD | GILEAD SCIENCES INC | 7K | $500K+ | SH |
| AVTR | AVANTOR INC | 70K | $500K+ | SH |
| AVTR | AVANTOR INC | 70K | $500K+ | SH |
| ARE | ALEXANDRIA REAL ESTATE EQ IN | 16K | $500K+ | SH |
| ARE | ALEXANDRIA REAL ESTATE EQ IN | 16K | $500K+ | SH |
| LUNG | PULMONX CORP | 355K | $500K+ | SH |
| LUNG | PULMONX CORP | 355K | $500K+ | SH |
| IBIO | IBIO INC | 406K | $500K+ | SH |
| IBIO | IBIO INC | 406K | $500K+ | SH |
| TENX | TENAX THERAPEUTICS INC | 64K | $500K+ | SH |
| TENX | TENAX THERAPEUTICS INC | 64K | $500K+ | SH |